leisure time -WSS

leisure time

author：Wikipedia 2025-08-25 07:29:35 - browse：7

Scanned cerebellum of a mouse brain, affected by Niemann-Pick Type C, shown in pink and teal — biotech coverage from STAT — The cerebellum of a mouse brain affected by Niemann-Pick Type C. Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health

About a decade ago, Tatiana Bremova-Ertl’s graduate adviser was studying an obscure, 1950s-era French vertigo drug, probing its effects on people with balance disorders, when she thought of another, very sick group of patients.

A graduate student and medical resident at the German Center for Vertigo and Balance Disorders, in Munich, Bremova-Ertl often saw patients with Niemann-Pick Type C, a rare, genetic disease that slowly kills neurons.

NPC has a range of manifestations. When symptoms appear in early childhood, it is often fatal before adulthood. When it manifests later, it can be milder. But it’s always degenerative and leads to a cluster of challenges: cognitive decline, difficulty with speech and swallowing, enlarged liver, low muscle tone, and, notably, difficulty with balance and muscle control. Researchers and a fervent group of parents were working to develop medicines, but little had yet worked.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： The public health thinking behind the CDC’s new Covid guidance

explore

WSS

Finland to offer bird flu vaccine to select groups of people, a possible global first

Longer MASH drug regimen improved liver, Akero study finds

A new initiative will help leaders fight the next pandemic

'Little Tech' descents on D.C., wanting a say in how AI is regulated

UnitedHealth CEO's Medicaid comments send insurer stocks diving

BD to buy Edwards patient monitoring unit for $4.2 billion

knowledge

leisure time

Wikipedia

How one medical school became remarkably diverse

State of the Union pitch: Bigger Medicare drug price negotiations

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

ASCO Daily Recap: CAR

Activists slam private health insurers over coverage restrictions

An outdated Medicare rule harms dementia patients with anxiety

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Families look for replacement for GSK asthma drug Flovent

How to save PrEP access — and even expand it

Eli Lilly’s Zepbound improved liver scarring in mid

focus

The untold story of TV’s first prescription drug ad

FTC loses bid to block Novant's North Carolina hospital merger

ASCO Daily Recap: CAR

Change Healthcare: What is it, why does its cyberattack matter?

How CO2 helps viruses stay alive longer in the air

Longer MASH drug regimen improved liver, Akero study finds

entertainment

explore

explore

explore